Antiviral drugs from basic discovery through clinical trials /
Spremljeno u:
| Autor kompanije: | |
|---|---|
| Daljnji autori: | |
| Format: | Elektronički e-knjiga |
| Jezik: | engleski |
| Izdano: |
Hoboken, N.J. :
Wiley,
c2011.
|
| Teme: | |
| Online pristup: | An electronic book accessible through the World Wide Web; click to view |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Sadržaj:
- pt. 1. Human immunodeficiency virus. section 1. HIV protease inhibitors ; section 2. HIV non-nucleoside reverse transcriptase inhibitors ; section 3. HIV nucleoside reverse transcriptase inhibitors ; section 4. HIV entry inhibitors ; section 5. HIV integrase inhibitors
- pt. 2. Hepatitis C virus. section 6. Protease inhibitors ; section 7. HCV polymerase nucleoside inhibitors ; section 8. Other HCV inhibitors
- pt. 3. Respiratory syncytial virus inhibitors
- pt. 4. Influenza, Hepatitis B, and Cytomegalovirus inhibitors.